Various pathogenic mechanisms common in people with CAD risk factors, such as cholesterol crystals, tissue hypoxia, and abnormal arterial flow patterns, can promote the activation of the NLRP3 inflammasome [38–41], which then activates IL-1β. The gene discussed is IL1B; the disease is coronary artery disorder.